Novo’s semaglutide, the drug inside of Ozempic and Wegovy, and Lilly’s tirzepatide, the drug inside Zepbound and Mounjaro, sit on the vanguard of a increasing course of drugs called GLP-1 agonists. These medication mimic the action of the intestine hormone involved with regulating starvation and blood sugar and just after initially becoming dep